Barclays PLC Synlogic, Inc. Transaction History

Barclays PLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.27 - $3.0 $19,008 - $25,122	-8,374 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$2.45 - $4.1 $8,322 - $13,927	3,397 Added 68.25%	8,374 $26,000
Q2 2021 Aug 13, 2021	BUY	$3.0 - $4.39 $14,097 - $20,628	4,699 Added 1690.29%	4,977 $19,000
Q1 2021 May 13, 2021	BUY	$2.2 - $5.05 $611 - $1,403	278 New	278 $1,000
Q3 2020 Nov 12, 2020	SELL	$1.85 - $2.57 $7,797 - $10,832	-4,215 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$1.59 - $2.51 $1,504 - $2,374	-946 Reduced 18.33%	4,215 $9,000
Q1 2020 May 13, 2020	SELL	$1.39 - $3.19 $15,319 - $35,156	-11,021 Reduced 68.11%	5,161 $9,000
Q4 2019 Feb 10, 2020	BUY	$1.96 - $2.81 $2,622 - $3,759	1,338 Added 9.01%	16,182 $41,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $9.37 $4,013 - $17,737	-1,893 Reduced 11.31%	14,844 $34,000
Q2 2019 Aug 14, 2019	BUY	$6.27 - $9.48 $34,021 - $51,438	5,426 Added 47.97%	16,737 $152,000
Q1 2019 May 15, 2019	BUY	$7.01 - $10.24 $14,419 - $21,063	2,057 Added 22.23%	11,311 $86,000
Q4 2018 Feb 14, 2019	SELL	$5.95 - $14.49 $33,831 - $82,390	-5,686 Reduced 38.06%	9,254 $65,000
Q3 2018 Nov 14, 2018	BUY	$7.51 - $14.21 $57,271 - $108,365	7,626 Added 104.27%	14,940 $212,000
Q2 2018 Aug 14, 2018	BUY	$9.01 - $13.33 $36,166 - $53,506	4,014 Added 121.64%	7,314 $72,000
Q1 2018 May 15, 2018	SELL	$9.38 - $12.12 $64,722 - $83,628	-6,900 Reduced 67.65%	3,300 $31,000
Q4 2017 Feb 14, 2018	BUY	$9.15 - $18.9 $93,330 - $192,780	10,200	10,200 $99,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.